What Researchers Did
Researchers studied C-peptide levels in 45 patients with type 1 diabetes before and during hyperbaric oxygen therapy.
What They Found
After 10-12 hyperbaric oxygen sessions, the therapy stimulated residual insulin secretion in type 1 diabetes patients. This effect was observed in those who had diabetes for less than 3 years, used less than 60 units of insulin daily, had less than 10% excess body weight, and had retinopathy no worse than stage I.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
A limitation of this study is its age (1987) and relatively small number of participants, which may affect how broadly its findings can be applied today.